Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Baghaie, S. Khalilzadeh, M. R. Boloursaz, A. A. Velayati (Tehran, Islamic Republic Of Iran). Pulmonary hypertension in cystic fibrosis patients. Eur Respir J 2008; 32: Suppl. 52, 2871

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Pulmonary hypertension as a predictor of survival in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 230s Year: 2003 Pulmonary fibrosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 618s Year: 2004 Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Electrocardiographical characteristics of pulmonary arterial hypertension in children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction Source: Eur Respir J 2015; 46: 1370-1377 Year: 2015 The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Pulmonary fibrosis Source: Eur Respir Mon; 2009: 45: 46–53 Year: 2009 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013